Literature DB >> 7519237

Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity.

J Bigda1, I Beletsky, C Brakebusch, Y Varfolomeev, H Engelmann, J Bigda1, H Holtmann, D Wallach.   

Abstract

Whereas there is ample evidence for involvement of the p55 tumor necrosis factor (TNF) receptor (p55-R) in the cytocidal effect of TNF, the role of the p75 TNF receptor (p75-R) in this effect is a matter of debate. In this study, we probed the function of p75-R in cells sensitive to the cytotoxicity of TNF using a wide panel of antibodies (Abs) against the receptor's extracellular domain. Two distinct Ab effects were observed. The Abs triggered signaling for cytotoxicity. This effect: (a) was correlated with the extent of p75-R expression by the cells; (b) was dependent on receptor cross-linking by the Abs; (c) occurred in HeLa cells, but not in A9 cells transfected with human p75-R or in HeLa cells expressing cytoplasmically truncated p75-R mutants, indicating that it involves cell-specific activities of the intracellular domain of the receptor; (d) was synergistic with the cytocidal effect of Abs against p55-R. Moreover, it seemed to reverse induced desensitization to the cytocidal effect of anti p55-R Abs, suggesting that it involves mechanisms different from those of the signaling by the p55 TNF-R. In addition, the Abs affected the response to TNF in a way that does not involve the signaling activity of p75-R. These effects: (a) could be observed also in cells in which only p55-R signaled for the cytocidal effect; (b) were not dependent on receptor cross-linking by the Abs; (c) varied according to the site at which the Abs bound to the receptor; and (d) were correlated inversely with the effects of the Abs on TNF binding to p75-R. That is, Abs binding to the membrane-distal part of the receptor's extracellular domain displaced TNF from the p75 receptor and enhanced cytocidal effect, whereas Abs that bind to the membrane-proximal part of the extracellular domain--a region at which a conformational change seems to take place upon TNF binding--decreased the dissociation of TNF from p75-R and inhibited its cytocidal effect. The above findings suggest that p75-R contributes to the cytocidal effect of TNF both by its own signaling and by regulating the access of TNF to p55-R.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7519237      PMCID: PMC2191585          DOI: 10.1084/jem.180.2.445

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  61 in total

1.  cDNA sequences of two inducible T-cell genes.

Authors:  B S Kwon; S M Weissman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

2.  Binding of human TNF-alpha to high-affinity cell surface receptors: effect of IFN.

Authors:  S Israel; T Hahn; H Holtmann; D Wallach
Journal:  Immunol Lett       Date:  1986-04       Impact factor: 3.685

3.  Expression and structure of the human NGF receptor.

Authors:  D Johnson; A Lanahan; C R Buck; A Sehgal; C Morgan; E Mercer; M Bothwell; M Chao
Journal:  Cell       Date:  1986-11-21       Impact factor: 41.582

4.  Properties of the insulin receptor ectodomain.

Authors:  J D Johnson; M L Wong; W J Rutter
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

5.  Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor.

Authors:  P Seckinger; S Isaaz; J M Dayer
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

6.  A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity.

Authors:  H Engelmann; D Aderka; M Rubinstein; D Rotman; D Wallach
Journal:  J Biol Chem       Date:  1989-07-15       Impact factor: 5.157

7.  Interrelated effects of tumor necrosis factor and interleukin 1 on cell viability.

Authors:  H Holtmann; T Hahn; D Wallach
Journal:  Immunobiology       Date:  1988-04       Impact factor: 3.144

8.  Isolation and characterization of a tumor necrosis factor binding protein from urine.

Authors:  I Olsson; M Lantz; E Nilsson; C Peetre; H Thysell; A Grubb; G Adolf
Journal:  Eur J Haematol       Date:  1989-03       Impact factor: 2.997

9.  Vectors for efficient expression in mammalian fibroblastoid, myeloid and lymphoid cells via transfection or infection.

Authors:  P Artelt; C Morelle; M Ausmeier; M Fitzek; H Hauser
Journal:  Gene       Date:  1988-09-07       Impact factor: 3.688

10.  A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas.

Authors:  I Stamenkovic; E A Clark; B Seed
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

View more
  23 in total

1.  The 75-kD tumour necrosis factor (TNF) receptor is specifically up-regulated in monocytes during Q fever endocarditis.

Authors:  E Ghigo; C Capo; N Amirayan; D Raoult; J Mege
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Activation and crosstalk between TNF family receptors in umbilical cord blood cells is not responsible for loss of engraftment capacity following culture.

Authors:  Keren Mizrahi; Nadir Askenasy
Journal:  Am J Stem Cells       Date:  2013-12-22

Review 3.  An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.

Authors:  Angela Panoskaltsis-Mortari; Matthias Griese; David K Madtes; John A Belperio; Imad Y Haddad; Rodney J Folz; Kenneth R Cooke
Journal:  Am J Respir Crit Care Med       Date:  2011-05-01       Impact factor: 21.405

4.  Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock.

Authors:  D Aderka; P Sorkine; S Abu-Abid; D Lev; A Setton; A P Cope; D Wallach; J Klausner
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

5.  High-fat diet-induced obesity and insulin resistance were ameliorated via enhanced fecal bile acid excretion in tumor necrosis factor-alpha receptor knockout mice.

Authors:  Mayumi Yamato; Takeshi Shiba; Tomomi Ide; Naoko Seri; Wataru Kudo; Makoto Ando; Ken-ichi Yamada; Shintaro Kinugawa; Hiroyuki Tsutsui
Journal:  Mol Cell Biochem       Date:  2011-08-18       Impact factor: 3.396

6.  Tumour necrosis factor-induced activation of c-Jun N-terminal kinase is sensitive to caspase-dependent modulation while activation of mitogen-activated protein kinase (MAPK) or p38 MAPK is not.

Authors:  Ahmed A A Mohamed; Orla J Jupp; Helen M Anderson; Alison F Littlejohn; Peter Vandenabeele; David J MacEwan
Journal:  Biochem J       Date:  2002-08-15       Impact factor: 3.857

7.  Differential regulation of cytokine and cytokine receptor mRNA expression upon infection of bone marrow-derived macrophages with Listeria monocytogenes.

Authors:  A Demuth; W Goebel; H U Beuscher; M Kuhn
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

8.  A role for TNF receptor type II in leukocyte infiltration into the lung during experimental idiopathic pneumonia syndrome.

Authors:  Gerhard C Hildebrandt; Krystyna M Olkiewicz; Leigh Corrion; Shawn G Clouthier; Elizabeth M Pierce; Chen Liu; Kenneth R Cooke
Journal:  Biol Blood Marrow Transplant       Date:  2008-04       Impact factor: 5.742

9.  Tumour necrosis factor receptors and apoptosis of alveolar macrophages during early infection with attenuated and virulent Mycobacterium bovis.

Authors:  Michele F Rodrigues; Caio C S Alves; Bárbara B M Figueiredo; Alice B Rezende; Sabine Wohlres-Viana; Vânia Lúcia da Silva; Marco Antônio Machado; Henrique C Teixeira
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

10.  Potentiation of antitumor effects of tumor necrosis factor alpha and interferon gamma by macrophage-colony-stimulating factor in a MmB16 melanoma model in mice.

Authors:  W Lasek; A Wańkowicz; K Kuc; W Feleszko; J Gołab; A Giermasz; W Wiktor-Jedrzejczak; M Jakóbisiak
Journal:  Cancer Immunol Immunother       Date:  1995-05       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.